OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Microbiology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	160
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	83
TREM-2: friend or foe in infectious diseases?	75
Helicobacter pylori infection: from standard to alternative treatment strategies	66
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	59
Salmonella in eggs and egg-laying chickens: pathways to effective control	55
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	49
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	43
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	42
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	41
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	41
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	39
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	37
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	34
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	33
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	31
LysR-type transcriptional regulators: state of the art	30
Applications of bacteriophages against intracellular bacteria	29
Exploring halophilic environments as a source of new antibiotics	28
Vibrio cholerae virulence and its suppression through the quorum-sensing system	27
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	26
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	26
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	25
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	25

Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge